153 related articles for article (PubMed ID: 16108069)
21. Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice.
Young CS; Palma JM; Mosher BD; Harkema J; Naylor DF; Dean RE; Crockett E
Am Surg; 2001 Aug; 67(8):737-44. PubMed ID: 11510573
[TBL] [Abstract][Full Text] [Related]
22. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.
Bedirli N; Ofluoglu E; Kerem M; Utebey G; Alper M; Yilmazer D; Bedirli A; Ozlu O; Pasaoglu H
Anesth Analg; 2008 Mar; 106(3):830-7, table of contents. PubMed ID: 18292427
[TBL] [Abstract][Full Text] [Related]
23. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury.
Tsung A; Stang MT; Ikeda A; Critchlow ND; Izuishi K; Nakao A; Chan MH; Jeyabalan G; Yim JH; Geller DA
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1261-8. PubMed ID: 16410367
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
[TBL] [Abstract][Full Text] [Related]
26. [Protective effect of N-acetyl-L-cysteine on liver and lung injury in mice after partial hepatic ischemia/reperfusion].
Wu HS; Jin X; Tian Y; Zhang JH; Wang CY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):394-7. PubMed ID: 17631703
[TBL] [Abstract][Full Text] [Related]
27. Ryanodine receptor antagonism protects the ischemic liver and modulates TNF-alpha and IL-10.
López-Neblina F; Toledo-Pereyra LH; Toledo AH; Walsh J
J Surg Res; 2007 Jun; 140(1):121-8. PubMed ID: 17359999
[TBL] [Abstract][Full Text] [Related]
28. The protective effect of CAPE on hepatic ischemia/reperfusion injury in rats.
Saavedra-Lopes M; Ramalho FS; Ramalho LN; Andrade-Silva A; Martinelli AL; Jordão AA; Castro-e-Silva O; Zucoloto S
J Surg Res; 2008 Dec; 150(2):271-7. PubMed ID: 18621400
[TBL] [Abstract][Full Text] [Related]
29. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
30. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Fiorini RN; Donovan JL; Rodwell D; Evans Z; Cheng G; May HD; Milliken CE; Markowitz JS; Campbell C; Haines JK; Schmidt MG; Chavin KD
Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning.
Matsumoto T; O'Malley K; Efron PA; Burger C; McAuliffe PF; Scumpia PO; Uchida T; Tschoeke SK; Fujita S; Moldawer LL; Hemming AW; Foley DP
Surgery; 2006 Nov; 140(5):793-802. PubMed ID: 17084723
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.
Yoshida K; Oida H; Kobayashi T; Maruyama T; Tanaka M; Katayama T; Yamaguchi K; Segi E; Tsuboyama T; Matsushita M; Ito K; Ito Y; Sugimoto Y; Ushikubi F; Ohuchida S; Kondo K; Nakamura T; Narumiya S
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4580-5. PubMed ID: 11917107
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte NF-kappaB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia.
Kuboki S; Okaya T; Schuster R; Blanchard J; Denenberg A; Wong HR; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G201-7. PubMed ID: 16950761
[TBL] [Abstract][Full Text] [Related]
34. Effects of tetrandrine on ischemia/reperfusion injury in mouse liver.
Cheng F; Li Y; Feng L; Li S
Transplant Proc; 2008 Sep; 40(7):2163-6. PubMed ID: 18790181
[TBL] [Abstract][Full Text] [Related]
35. The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration.
Jiang GL; Nieves A; Im WB; Old DW; Dinh DT; Wheeler L
J Pharmacol Exp Ther; 2007 Jan; 320(1):22-8. PubMed ID: 17008451
[TBL] [Abstract][Full Text] [Related]
36. Rho-kinase mediates spinal nitric oxide formation by prostaglandin E2 via EP3 subtype.
Matsumura S; Abe T; Mabuchi T; Katano T; Takagi K; Okuda-Ashitaka E; Tatsumi S; Nakai Y; Hidaka H; Suzuki M; Sasaki Y; Minami T; Ito S
Biochem Biophys Res Commun; 2005 Dec; 338(1):550-7. PubMed ID: 16188227
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.
Chung KF
Sci STKE; 2005 Sep; 2005(303):pe47. PubMed ID: 16189372
[TBL] [Abstract][Full Text] [Related]
38. Lack of a protective effect of insulin on three reperfusion-liver injury models in rats and mice.
Chen CF; Leu FJ; Chen HI; Wang D; Chou SJ
Transplant Proc; 2006 Sep; 38(7):2221-5. PubMed ID: 16980048
[TBL] [Abstract][Full Text] [Related]
39. Protective mechanism of beta-SQAG9 liposome, a sulfonoglycolipid extracted from sea urchin intestines, against hepatic ischemia reperfusion injury.
Shima H; Tsuruma T; Sahara H; Takenouchi M; Takahashi N; Iwayama Y; Yagihashi A; Watanabe N; Sato N; Hirata K
Shock; 2007 Jul; 28(1):94-100. PubMed ID: 17483740
[TBL] [Abstract][Full Text] [Related]
40. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury.
Llacuna L; Marí M; Garcia-Ruiz C; Fernandez-Checa JC; Morales A
Hepatology; 2006 Sep; 44(3):561-72. PubMed ID: 16941686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
